Chembio Diagnostics Inc. (CEMI)

8.66
0.09 1.03
NASDAQ : Health Technology
Prev Close 8.75
Open 8.60
Day Low/High 8.56 / 8.70
52 Wk Low/High 5.70 / 9.20
Volume 3.72K
Avg Volume 21.70K
Exchange NASDAQ
Shares Outstanding 14.16M
Market Cap 125.34M
EPS -0.50
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Chembio Diagnostics Announces Completion Of U.S. Clinical Trial Evaluating DPP® HIV-Syphilis System

Chembio Diagnostics Announces Completion Of U.S. Clinical Trial Evaluating DPP® HIV-Syphilis System

U.S. Regulatory Submission for DPP® HIV-Syphilis System Expected in Q1 2018

Chembio Receives $8.5 Million Commitment From Bio-Manguinhos To Purchase Components For Production Of DPP® Assays In Brazil During 2018

Chembio Receives $8.5 Million Commitment From Bio-Manguinhos To Purchase Components For Production Of DPP® Assays In Brazil During 2018

Chembio Receives $4.2 Million in Accounts Receivable Payments from Bio-Manguinhos

Chembio Diagnostics Reports Third Quarter 2017 Financial Results

Chembio Diagnostics Reports Third Quarter 2017 Financial Results

Conference Call and Webcast Today at 4:30 p.m. Eastern Time

Chembio To Host Conference Call To Discuss Third Quarter 2017 Financial Results

Chembio To Host Conference Call To Discuss Third Quarter 2017 Financial Results

Conference Call Scheduled for Wednesday, November 8th at 4:30 p.m. Eastern Time

Chembio Diagnostics Reports Second Quarter 2017 Financial Results

Chembio Diagnostics Reports Second Quarter 2017 Financial Results

Conference Call and Webcast Today at 4:30 p.m. Eastern Time

Chembio To Host Conference Call To Discuss Second Quarter 2017 Financial Results

Chembio To Host Conference Call To Discuss Second Quarter 2017 Financial Results

Conference Call Scheduled for Wednesday, August 9th at 4:30 p.m. Eastern Time

Gail S. Page Joins Chembio Diagnostics Board Of Directors

Gail S. Page Joins Chembio Diagnostics Board Of Directors

Adds Additional Diagnostic Industry Leadership and Healthcare Expertise

Chembio Diagnostics Reports First Quarter 2017 Financial Results

Conference Call and Webcast Today at 4:30 p.m. Eastern Time

Chembio Secures $5.8 Million Bio-Manguinhos Order To Supply Components For Production Of DPP® HIV 1/2 Assay In Brazil

Chembio NY Facility Receives GMP Certification from Brazil's Health Agency

Chembio To Host Conference Call To Discuss First Quarter 2017 Financial Results

Conference Call Scheduled for Tuesday, May 9th at 4:30 p.m. Eastern Time

Chembio Diagnostics Reports 2016 Financial Results

Conference Call and Webcast Today at 4:30 p.m. Eastern Time

Chembio To Host Conference Call To Discuss 2016 Financial Results

Conference Call Scheduled for Tuesday, March 7th at 4:30 p.m. Eastern Time

Chembio's DPP® HIV-Syphilis Assay Receives CE Mark For Simultaneous Point-of-Care Detection Of HIV And Syphilis

Chembio's DPP® HIV-Syphilis Assay Receives CE Mark For Simultaneous Point-of-Care Detection Of HIV And Syphilis

DPP® HIV-Syphilis Assay on Track for U.S. Regulatory Submission in 2017

Chembio Completes Acquisition Of Malaysia-based RVR Diagnostics

Chembio Completes Acquisition Of Malaysia-based RVR Diagnostics

RVR to Serve as Manufacturing and Distribution Facility for APAC Operations

Chembio Diagnostics Reports Third Quarter 2016 Financial Results

Chembio Diagnostics Reports Third Quarter 2016 Financial Results

Conference Call and Webcast Today at 10:00 a.m. Eastern Time